Web Analytics Made Easy -

Milind Deshpande, PhD

Board Member

Milind Deshpande, PhD, is a Director of Clear Creek Bio. Milind is a Venture Partner at RA Capital and is a founder CEO of several RA Capital portfolio companies. Milind also serves as the Chairman of the Board of Directors of Spero Therapeutics, a publicly traded company developing novel antibiotics. Milind was the President, CEO, and Board member at Achillion Pharmaceuticals from 2013-2018. He joined Achillion in 2001, and led the R&D organization prior to assuming the role of President & CEO. Prior to joining Achillion, Milind was Group Leader at Bristol-Myers Squibb, where he led discovery and development of clinical candidates to treat infectious and neurological diseases. From 1988 to 1991, he held a faculty position at Boston University Medical School. Milind received his PhD in organic chemistry from Ohio University, following his undergraduate education in India.

585 Massachusetts Avenue, 4th Floor 
Cambridge, MA 02139

  • Twitter

© Clear Creek Bio, Inc. 2020  |  Privacy Policy  Terms